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1  | INTRODUC TION
The role of metabolic cues in pubertal progression has been well de-
scribed in different mammalian species.1-4 Among these cues, the 
adipocyte-derived hormone leptin plays a critical role. The circulat-
ing levels of leptin are positively correlated with the amount of body 
fat.5-7 Disruption of leptin signalling causes obesity, diabetes and a 
number of neuroendocrine dysfunctions, including changes in bone 
accrual and growth, pubertal arrest and infertility.5,8-17 Genetic mu-
tations of leptin or leptin receptor in humans are rare.11,18,19 Obese 
individuals exhibit hyperleptinaemia with a low or absent response 
to leptin administration.20,21 The underlying mechanisms are di-
verse, although impairment of leptin receptor signalling appears to 
play a major role. Therefore, leptin “resistance” as a result of the dis-
ruption of leptin receptor (LR) function or signalling capacity may 
cause most of the metabolic and neuroendocrine deficits observed 
in obese subjects.22,23 Excess adiposity and high leptin levels also 
impact reproductive function and growth by disrupting steroidogen-
esis in males and females, aggravating ovulatory disorders, and al-
tering bone formation.17,23-27 The increasing prevalence of childhood 
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Nutrition and growth are important signals for pubertal development, although how 
they are perceived and integrated in brain circuits has not been well defined. Growth 
hormones and metabolic cues both recruit phosphatidylinositol 3-kinase (PI3K) sig-
nalling in hypothalamic sites, although whether they converge into the same neu-
ronal population(s) is also not known. In this review, we discuss recent findings from 
our laboratory showing the role of PI3K subunits in cells directly responsive to the 
adipocyte-derived hormone leptin in the coordination of growth, pubertal develop-
ment and fertility. Mice with deletion of PI3K p110α and p110β catalytic subunits in 
leptin receptor cells (LRΔα+β) have a lean phenotype associated with increased energy 
expenditure, locomotor activity and thermogenesis. The LRΔα+β mice also show defi-
cient growth and delayed puberty. Deletion of a single subunit (ie, p110α) in LR cells 
(LRΔα) causes a similar phenotype of increased energy expenditure, deficient growth 
and delayed pubertal development, indicating that these functions are preferably 
controlled by p110α. The LRΔα mice show enhanced leptin sensitivity in metabolic 
regulation but, remarkably, these mice are unresponsive to the effects of leptin on 
growth and puberty. PI3K is also recruited by insulin and a subpopulation of LR neu-
rones is responsive to i.c.v. insulin administration. Deletion of insulin receptor in LR 
cells causes no changes in body weight or linear growth and induces only a mild delay 
in pubertal completion. Our findings demonstrate that PI3K in LR cells plays an es-
sential role in growth and reproduction. We will also discuss the potential neural 
pathways underlying these effects.
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obesity has been associated with early puberty in girls.28-30 Thus, it 
has become clear that metabolic cues are key for the coordinated 
timing of growth and puberty and maintenance of a healthy repro-
ductive function in adult life.
The LR is a member of the class I cytokine receptor family com-
prised of several isoforms.10,31-35 The LR long form (LRb) contains 
three intracellular tyrosine residues that are phosphorylated by 
JAK2.	 Selective	 blockade	 of	 each	 one	 of	 these	 residues	 has	 pro-
duced compelling findings regarding the effects of specific signalling 
pathways in leptin function.36-38 For example, disruption of Tyr1138 
or leptin-induced signal transducer and activator of transcription 
(STAT) 3 signalling generates severely obese mice, with disruption 
of thyroid and adrenal axes. However, these mice show improved 
glucose homeostasis, growth and fertility compared to loss-of-func-
tion mutation of leptin or leptin receptor genes (ie, ob/ob or Lepob 
and db/db or Leprdb mice). Lack of either leptin-induced SHP2-ERK 
(Tyr985) or STAT5 (Tyr1077) caused only mild metabolic or repro-
ductive phenotypes.37-39
Leptin also recruits phosphatidylinositol 3-kinase (PI3K) sig-
nalling,40-43 a major molecular pathway associated with metabolic 
regulation, insulin signalling, glucose homeostasis and neuroendo-
crine function.40,42,44-49 However, the requirement of PI3K in leptin 
responsive cells for growth and pubertal maturation had not been 
described until very recently.50 In this review, we discuss findings 
showing that PI3K signalling functions as a key molecular pathway 
linking leptin and the neuroendocrine axes. Because PI3K is also re-
cruited by insulin, we discuss its potential role in the integration of 
both metabolic cues.43,51,52
2  | PI3K IN LEPTIN AC TION: MOLECUL AR 
COMPONENTS
Studies from different groups support the hypothesis that leptin re-
cruits the PI3K signalling pathway to exert some of its effects.40,42 
For example, leptin hyperpolarises a subset of arcuate nucleus neu-
rones via activation of an ATP sensitive potassium channel, resulting 
in reduced firing rates. Inhibitors of PI3K blocked this effect.44,53,54 
Similarly, leptin-mediated depolarising effects on pro-opiomelano-
cortin (POMC) neurones are dependent on PI3K signalling.55 
Pharmacological inhibition of PI3K blocked the ability of i.c.v. leptin 
to reduce food intake40,44 and precluded the effects of hypothalamic 
leptin administration to inhibit white adipose tissue lipogenesis.56
Multiple classes of PI3Ks exist. In particular, class IA is primar-
ily associated with metabolic regulation.57-59 PI3K class IA consists 
of heterodimers of one regulatory and one catalytic subunit. There 
are typically five regulatory subunits, often called the p85s, and the 
catalytic subunits comprise three variants referred to as p110s.57,59 
Activation of the heterodimers occurs when the p85 binds to the in-
sulin receptor substrate (IRS) and position the catalytic subunit in the 
cellular membrane, where PI3K catalyses the phosphorylation of the 
phosphatidylinositol bisphosphate to PIP3, which, in turn, recruits 
and activates downstream pathways.
The p110α and p110β subunits are ubiquitously expressed, 
whereas the p110γ is almost absent in the brain.60,61 Because 
of the distribution pattern and the lack of p110γ in hypothalamic 
sites, most of the studies in metabolic control have focused on the 
roles of p110α and p110β subunits. Mice lacking p110α or p110β 
die early during embryonic development.62,63 However, mice car-
rying a knockin mutation causing a 50% loss-of-function of p110α 
activity (kinase-dead/D993A) are viable, although they display 
suppressed IRS signalling, decreased responsiveness to insulin and 
leptin, reduced linear growth, hyperphagia and increased adipos-
ity.47 Deletion of p110α in cells expressing POMC or steroidogenesis 
factor 1 (SF1) decreased energy expenditure and increased suscep-
tibility to high-fat diet.64,65
These initial findings suggested that the p110α was the main iso-
form downstream of leptin or insulin action. However, subsequent 
studies showed that the isoform interactions are more complex 
than previously anticipated. Insulin-induced phosphorylation of Akt 
(pAkt) is only partially blocked by inhibitors of either p110α or p110β, 
whereas the administration of both inhibitors completely prevented 
insulin signalling. Likewise, the combined administration of p110α 
and p110β inhibitors blocked the acute anorexigenic action of leptin 
and insulin.66 Intact p110β or both p110α and p110β subunits in 
neurones expressing agouti-related protein (AgRP) appear to be re-
quired for metabolic control.67,68 In SF1 neurones, distinct catalytic 
subunits are necessary for leptin or insulin cellular effects.69 Thus, 
it soon became clear that blockade of PI3K downstream of leptin 
would only be attained by deletion of both subunits. This concept is 
further strengthened by data showing that LR neurones coexpress 
both p110α and p110β subunits.70
3  | EFFEC TS OF DELETION OF P110α  AND 
P110β  SUBUNITS IN LR NEURONES
To assess the direct role of PI3K downstream of leptin, we generated 
mice with deletion of both p110α and p110β catalytic subunits in LR 
cells.50,70,71 The experimental group was comprised of mice homozy-
gous for three alleles: LR-Cre, p110α-floxed and p110β-floxed,48,72,73 
named LRΔα+β. We used LR-Cre homozygous mice because, in pre-
liminary studies, we found only partial deletion of PI3K in LR cells 
of heterozygous LRCre/+ mice harvested by fluorescence activated 
cell sorting.50 This finding is also in agreement with previous studies 
using a different LR-Cre mouse line.74-76 To assess whether Cre in 
homozygosity alters LR function, we performed a systematic evalu-
ation of LRcre/cre mouse phenotype. No ectopic expression of Cre 
(using reporter genes) and no metabolic, growth or reproductive 
deficits were observed.50
Male and female mice were evaluated separately due to the 
sexually dimorphic responses in metabolic and neuroendocrine 
functions.77 Precautions were taken to avoid inconsistencies and 
exogenous interference in the physiological measurements. For ex-
ample, on postnatal day 1 (P1), litter size was kept consistent (equal 
in number) among groups and cohorts to avoid early-life nutritional 
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effects on body weight and metabolic programming.1,4,78 After 
weaning (P21), males and females were fed phyto-oestrogen-re-
duced diet to prevent the effects of exogenous oestrogens on pu-
bertal development and fertility. Body weights were measured 
weekly, and the metabolic phenotype was monitored by CLAMS 
(Comprehensive Laboratory Animal Monitoring System; Columbus 
Instruments, Columbus, OH, USA) using average values obtained 
from 3-4 days of metabolic recordings to avoid individual variations 
or random errors.
Briefly, male and female LRΔα+β mice showed a decreased body 
weight, starting at 4-5 weeks of age, associated with decreased 
lean and fat mass and decreased linear growth. They also showed 
an increased food intake (when normalised by body weight), en-
ergy expenditure, locomotor activity and brown adipose tissue 
Ucp1 expression, suggesting increased thermogenesis. Females 
(but not males) had delayed puberty determined by late vaginal 
opening (a sign of puberty onset) and delayed first oestrus (pu-
berty completion).50 Whether disruption of the actions of oestra-
diol as a result of PI3K imbalance in LR cells is the cause of the 
sexually dimorphic phenotype in reproductive function requires 
further evaluation.
These findings raised several questions that require additional 
studies. We initially focused on answering the following: (i) are indi-
vidual PI3K catalytic subunits associated with specific physiological 
control and (ii) is the delayed puberty in females caused by the de-
crease in body weight, fat mass or leptin levels?
4  | EFFEC TS OF DELETION OF P110α 
SUBUNITS IN LR NEURONES
To address the initial question, we generated a mouse line with dele-
tion of a single PI3K subunit, p110α, in LR cells. We chose p110α be-
cause of data from D993A mice showing that a half dosage of p110α 
induces changes in metabolic and growth phenotypes.47 To avoid 
potential confounders originating from the use of different genetic 
backgrounds, the mouse colony with deletion of p110α in LR cells 
(LRΔα) was derived from the LRΔα+β mice.
The LRΔα male and female mice showed decreased body weight, 
lean and fat mass, and reduced linear growth. Changes in growth 
were observed only in adults (around and after P60); no differences 
were observed before or during pubertal maturation (P40). Low bone 
mineral density was detected in the femoral trabecular and cortical 
layers associated with a decrease in hepatic growth hormone recep-
tor (Ghr) and insulin-like growth factor 1 (Igf1) expression in adult 
females. Similar to LRΔα+β mice, food intake was increased when nor-
malised by body weight. Increased energy expenditure and delayed 
pubertal maturation were observed. Female LRΔα mice also showed 
prolonged oestrous cycles and progressive subfertility. No changes 
in locomotor activity and brown adipose tissue uncoupling protein 1 
(Ucp1) gene expression were detected. Taken together, these find-
ings indicate that, apart from energy balance, the p110α subunit in 
LR cells is also necessary for typical growth and reproduction.
Because the LRΔα (and the LRΔα+β) mice had a low body weight, 
fat mass and leptin levels, we performed several metabolic manip-
ulations to assess whether the delayed puberty and reproductive 
phenotypes were secondary to the metabolic disruption. We started 
by applying the early postnatal overnutrition approach via manipu-
lation of the litter size.1,4,78 A cohort of mice was maintained in small 
litters in the attempt to increase or normalise the body weight of 
LRΔα mice prior to puberty onset. This manipulation was successful 
until weaning day, when LRΔα mice start to consistently decrease the 
weight gain. Timing of pubertal development and leptin levels were 
marginally improved, although not corrected. Again, because we 
still found a lean phenotype in the postnatal overnutrition paradigm 
after weaning, our question remained unanswered. We decided to 
use the leptin challenge instead.
Leptin treatment in small doses that do not alter metabolic re-
sponses was shown to advance puberty in rodents.79,80 We used a 
very similar approach and found that, although control mice had early 
puberty onset, LRΔα female mice were unresponsive to the effects 
of leptin on the timing of pubertal development. Another interesting 
finding from this experiment was the increased leptin sensitivity in 
metabolic regulation of the mutant mice potentially as a result of the 
increased basal levels of pAkt and leptin-induced phosphorylated 
STAT-3 and the decreased levels of the PIP3 phosphatase PTEN.50
Of further interest was the increased expression of AgRP mRNA 
and peptide in fed female LRΔα mice. The AgRP neurones are located 
in the arcuate nucleus and coexpress LR.45,81-83 Ablation of AgRP 
neurones (AgRPDTR mice) ameliorates the metabolic and reproduc-
tive phenotypes of leptin-deficient ob/ob mice. Improved fertility 
was also observed in LR-deficient db/db mice with global deletion of 
Agrp gene, and deletion of LR in AgRP neurones alters fertility.84-88 
Thus, changes in AgRP levels and/or signalling in LRΔα mice may ex-
plain the increased food intake, and the disruption of growth and 
pubertal development observed in LRΔα mice.87,89 It is also in agree-
ment with findings showing that PI3K is required for leptin actions 
on Agrp gene expression.45 Alternatively, ablation of PI3K may have 
affected the acute actions of leptin in the ventral premammillary 
nucleus, a hypothalamic site associated with leptin action in female 
reproductive function.70,74,90,91
5  | PROS AND CONS OF USING THE LR‐
CRE LINE A S A METABOLIC ALLY RELE VANT 
TARGET
LR expression is observed in many peripheral tissues and in the 
brain, with a high density in hypothalamic sites.10,92,93 Thus, whether 
the effects observed using the LR-Cre mice were a result of the de-
letion of PI3K in neurones or in other peripheral organs may appear 
somewhat unclear. In this regard, it is important to emphasise that 
studies using conditional deletion or re-expression of LR have shown 
that the effects of leptin in the neuroendocrine axes are mediated 
by the brain.94-96 The deletion of LR from gonadotrophs caused no 
changes in body weight, timing of pubertal maturation or oestrous 
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cycle duration.97 We have also shown that LR expression only in 
gonadotrophs is not sufficient to improve the metabolic or repro-
ductive phenotypes of the LR null mice.98 Similarly, initial studies 
have suggested that the reproductive deficits caused by a lack of 
leptin signalling are not mediated by the gonads,99 indicating that 
the brain is the main target of leptin in neuroendocrine regulation. 
However, the LRΔα mouse phenotype may not be entirely related 
to the disruption of leptin signalling. We could hypothesise that the 
lack of PI3K downstream of other hormones and/or growth factors 
in ovaries, for example, has contributed to the LRΔα mouse pheno-
type. LR-Cre reporter gene is expressed in theca cells 98 and studies 
have suggested that insulin signalling in theca cells is associated with 
an obesity-induced increase in oestrous cycle length.100 Deletion 
of insulin receptor in theca cells or gonadotrophs blocked this re-
sponse, allowing females to maintain normal oestrous cycles under 
obese conditions.100,101 Taken together, these findings suggest that 
the reproductive phenotype of the LRΔα mice is not associated with 
the deletion of PI3K in gonadotrophs or theca cells. As discussed 
earlier in this review, blunted PI3K signalling in LR cells of the ventral 
premammillary nucleus or the arcuate nucleus (ie, those coexpress-
ing AgRP) are prime candidates.
Leptin receptor is also expressed in the adipocytes, liver and 
osteoblasts.10,102,103 Whether deletion of PI3K subunits in LR cells 
of peripheral tissues may have impacted the growth and repro-
ductive phenotypes observed in our studies needs further evalu-
ation. However, it should be noted that deletion of p110α only in 
adipocytes resulted in a very distinct phenotype compared to that 
observed in our studies, such that delayed puberty and infertility 
were observed only in male (not female) mice.104 The mechanism(s) 
associated with this phenotype remain unknown. Moreover, no re-
productive or linear growth deficits have been described in mice 
with deletion of LR or disruption of PI3K class I in the liver.105,106
6  | COMPLE XIT Y OF PI3K SIGNALLING 
AND POTENTIAL CONFOUNDERS
The PI3K signalling pathway is comprised of intricate interactions of 
independent subunits and molecular targets. Thus, genetic modifica-
tions of specific subunits may cause an imbalance of the entire com-
plex, generating unexpected phenotypes. For example, mice with 
deletion of p85α or p85β regulatory subunits have improved insulin 
sensitivity and hypoglycaemia, despite PI3K being a key pathway for 
the effects of insulin in glucose homeostasis.58,107,108 The selective 
deletion of the p110 catalytic subunits in LR cells may have caused 
a similar response, such as an improvement of leptin sensitivity in 
energy homeostasis because of increases in energy expenditure and 
basal pAkt, a decrease in body weight and the potentiation of lep-
tin-induced phosphorylated STAT3. Notably, although the effects of 
leptin in metabolism were amplified in LRΔα mice, linear growth and 
reproductive function were compromised. These findings suggest 
that PI3K is a crucial downstream signal of metabolic cues to growth 
and the reproductive neuroendocrine axes.
Another potential confounder is the expression of LR in neurones 
with distinct or opposite functions, such as the AgRP and POMC 
neurones in the arcuate nucleus. Previous studies have assessed the 
role of PI3K subunits in AgRP, POMC and other neuronal popula-
tions (ie, SF1).64,65,67,68 Because only subsets of these neurones ex-
press LR, the results are ambiguous. It is not possible to determine 
whether the observed effects are associated with a lack of leptin, 
insulin or growth factors.69,109 Using the LR-Cre mouse model, we 
expect the data to be more specific, generating insights into the 
direct effects of leptin-induced PI3K in physiology. Further studies 
will be necessary to dissociate the role of specific LR neurones with 
respect to each of the phenotypic changes observed.
LR cells likely coexpress a number of receptors that also recruit 
PI3K signalling (eg, receptor tyrosine kinases or G protein-coupled 
receptors). Therefore, it is possible that the deletion of PI3K subunits 
has altered the signalling of other hormones and/or growth factors, 
producing a phenotype unrelated to the action of leptin. As already 
noted, one key hormone is insulin. By deleting PI3K from LR cells, we 
may have blocked the actions of insulin in subsets of LR neurones. 
To test this hypothesis, we used the Cre-loxP system to delete InsR 
from LR cells.
7  | EFFEC TS OF DELETION OF INSR IN LR 
CELL S
Previous studies using electrophysiological recordings have sug-
gested that leptin or insulin target distinct POMC and SF1 neuronal 
populations.69,109 However, a lack of changes in membrane potential 
does not preclude other cellular responses, such as gene expression 
and/or post-translational modifications. To assess whether down-
stream targets of insulin-induced PI3K with genomic actions may 
be detected in LR neurones, we performed a colocalisation study 
in the LR reporter mouse. Mice were treated with i.c.v. insulin to 
avoid potential confounders with respect to peripheral insulin ad-
ministration, and FoxO1 translocation or pAkt were identified in 
LR-Cre reporter neurones.50 Partial colocalisation was detected, 
reinforcing the hypothesis that the effects of PI3K deletion in LR 
cells were a result of a partial blockade of insulin signalling. To test 
this, we generated mice with deletion of InsR in LR cells, using the 
same LR-Cre mouse line bred with previously validated InsR-floxed 
mice.110 No deficits in growth and only minor changes in reproduc-
tive physiology were observed in the mutant mice. Females showed 
a mild delay in puberty completion, suggesting that a lack of insulin 
signalling in LR cells (LRΔInsR) may add to the effect observed in LRΔα 
and LRΔα+β mice showing a more severe disruption of pubertal tim-
ing. Interestingly, female LRΔInsR mice showed almost no metabolic 
dysfunction, whereas males had an increased fat mass and glucose 
oxidation but no reproductive deficits.50,111 We concluded that the 
changes in metabolic, growth and reproductive phenotypes of the 
LRΔα and LRΔα+β mice are not a result of the blockade of insulin sig-
nalling. Because the conditional deletion of InsR in the brain causes 
metabolic and reproductive deficits,110 our findings also indicate 
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that the actions of insulin in these physiological systems are attained 
by targeting cells distinct from those expressing LR. Whether other 
PI3K recruiting factors account for the effects observed in LRΔα and 
LRΔα+β mice requires further evaluation.
Genomic screening in humans has identified the PI3K as a key 
signalling pathway associated with pubertal development.112 In 
agreement, our findings obtained in mice show that PI3K signalling 
selectively in LR cells plays a major role. The decreased growth of 
LRΔα mice and the higher sensitivity to leptin in metabolic regulation 
make PI3K a potential target under conditions of delayed growth and 
puberty in humans, as well as in hypothalamic amenorrhoea associ-
ated with sustained negative energy balance.
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